Rv3033, as an emerging anti-apoptosis factor, facilitates mycobacteria survival via inhibiting macrophage intrinsic apoptosis

19Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Apoptosis inhibition is a critical strategy of mycobacteria facilitating its survival in macrophages, but the underlying mechanism is not completely understood. In this study, we found that Rv3033, a secreted virulence factor of mycobacteria, played an important role in bacillary survival within macrophages. Forced over-expressed of Rv3033 in macrophages could efficiently resist mycobacteria-induced early and late apoptosis, accompanied with the obvious increased cellular bacterial burden. By exploring the underlying mechanism, we found that Rv3033 efficiently repressed the intrinsic (caspase-9 meditated), but not the extrinsic (caspase-8 mediated) apoptotic pathway in mycobacteria-infected macrophages. And this repression relied on the orchestrating blockade of both mitochondrial cytochrome c release and endoplasmic reticulum (ER) stress PERK branch activation. Our study uncovered a novel function of mycobacterial virulence factor Rv3033 as an anti-apoptotic protein, which may provide a new target for tuberculosis (TB) treatment.

Cite

CITATION STYLE

APA

Zhang, W., Lu, Q., Dong, Y., Yue, Y., & Xiong, S. (2018). Rv3033, as an emerging anti-apoptosis factor, facilitates mycobacteria survival via inhibiting macrophage intrinsic apoptosis. Frontiers in Immunology, 9(SEP). https://doi.org/10.3389/fimmu.2018.02136

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free